Stentrode is the only implantable brain-computer interface that does not require open brain surgery and is currently in clinical trials SAN FRANCISCO & NEW YORK & MELBOURNE, Australia--(BUSINESS WIRE) ...
NEW YORK--(BUSINESS WIRE)--Synchron, a brain computer interface (BCI) company, today announced the results from a study in which four people with ALS received an implant of Synchron’s Stentrode™ ...
Synchron Inc.'s recent $200 million raise for its Stentrode brain-computer interface platform comes at a pivotal time for the technology. Advances in BCI development, ongoing clinical trials and ...
Apple has teamed up with Synchron to develop tech that lets people control its devices with thoughts
Apple has partnered with brain-computer interface maker Synchron to develop tech that lets consumers control devices like iPhones with their thoughts, according to a report by the Wall Street Journal.
Apple is collaborating with brain-computer interface company Synchron to develop technology that lets users control devices using neural signals. “This marks a defining moment for human-device ...
The brain-computer interface developer Synchron has laid out plans to build an artificial intelligence model trained on the language of cognition—instead of words or pictures—with programs that are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results